Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians

<i>Objectives:</i> To evaluate neurologists and other clinicians' contributions to U.S. ALS diagnostic timelines. <i>Background</i>: Over the past two decades, the average time to ALS diagnosis in the U.S. has remained unchanged at 12 months. ALS patients see 3-4 clinicians prior to referral to an ALS specialist for diagnosis confirmation and/or treatment initiation. There is an urgent need to identify where delays occur, so that targeted clinician awareness may be raised about early suspicion and referrals. <i>Methods</i>: Review of Medicare claims database for health care utilization patterns by ALS beneficiaries during diagnostic journey. Survey of typical clinic wait times for new consultations reported by 75-78 ALS Certified Treatment Centers of Excellence (2019-2021). <i>Results</i>: During 2011-2021, 78,520 Medicare beneficiaries were diagnosed with ALS (T0). The mean (median) timelines between first neurologist ambulatory visit and T0, is 16.5 (11.0) months; mean ± SD for ALS/neuromuscular providers being 9.6 ± 12.6 months versus 16.7 ± 17.5 months for non-neuromuscular neurologists. During the 12-months preceding T0, an ALS patient undergoes median(max) 1.5(4.0) brain-MRIs, 1.6(6.0) spine-MRIs, and 1.3(4.0) electromyography studies. Greater than 75% of ALS centers consistently report ≤ 4 week wait times for new ALS consults. This study introduces "thinkALS," an easy-to-use clinical diagnostic and referral guide for non-ALS neurologists to tackle this challenge. <i>Conclusions:</i> This study is the first to provide metrics on how non-neuromuscular/ALS specialists contribute to ALS diagnostic timelines in the U.S.

Authors

Institutions

Publication Details

Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Published
2024-12-10
DOI
https://doi.org/10.1080/21678421.2024.2432034
Citations
4
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
1.48

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians

Terry Heiman‐Patterson, Neil Thakur, Daniel R. Waldo, Ilisa Halpern Paul et al.
4 citations
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Amyotrophic Lateral Sclerosis Research
1.48
article

Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians

Terry Heiman‐Patterson, Neil Thakur, Daniel R. Waldo, Ilisa Halpern Paul, Suma Babu, Björn Oskarsson, Kuldip D. Dave, Melody Schaeffer, Wendy Selig, Jill Yersak, Ramona Krauss, Catherine Lomen‐Hoerth, Brittany Garcia-Trujillo
article en
4 citations

Abstract

<i>Objectives:</i> To evaluate neurologists and other clinicians' contributions to U.S. ALS diagnostic timelines. <i>Background</i>: Over the past two decades, the average time to ALS diagnosis in the U.S. has remained unchanged at 12 months. ALS patients see 3-4 clinicians prior to referral to an ALS specialist for diagnosis confirmation and/or treatment initiation. There is an urgent need to identify where delays occur, so that targeted clinician awareness may be raised about early suspicion and referrals. <i>Methods</i>: Review of Medicare claims database for health care utilization patterns by ALS beneficiaries during diagnostic journey. Survey of typical clinic wait times for new consultations reported by 75-78 ALS Certified Treatment Centers of Excellence (2019-2021). <i>Results</i>: During 2011-2021, 78,520 Medicare beneficiaries were diagnosed with ALS (T0). The mean (median) timelines between first neurologist ambulatory visit and T0, is 16.5 (11.0) months; mean ± SD for ALS/neuromuscular providers being 9.6 ± 12.6 months versus 16.7 ± 17.5 months for non-neuromuscular neurologists. During the 12-months preceding T0, an ALS patient undergoes median(max) 1.5(4.0) brain-MRIs, 1.6(6.0) spine-MRIs, and 1.3(4.0) electromyography studies. Greater than 75% of ALS centers consistently report ≤ 4 week wait times for new ALS consults. This study introduces "thinkALS," an easy-to-use clinical diagnostic and referral guide for non-ALS neurologists to tackle this challenge. <i>Conclusions:</i> This study is the first to provide metrics on how non-neuromuscular/ALS specialists contribute to ALS diagnostic timelines in the U.S.

Amyotrophic Lateral Sclerosis and Frontotemporal DegenerationVol. 26(3-4)
Harvard University (US), University of California, San Francisco (US), Temple College (US), WinnMed (US), Amyotrophic Lateral Sclerosis Association (US), Massachusetts General Hospital (US), Amplyx Pharmaceuticals (United States) (US), Mayo Clinic in Florida (US), The Stables (GB), Actuarial Research Corporation (US), Temple University (US)
ALS Association
Openalex Percentile: Top 16%
Amyotrophic Lateral Sclerosis Research
1.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.